Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancer

Tao Lu, Swati S. Sathe, Shannon M. Swiatkowski, Chetan V. Hampole, George R. Stark

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The constitutive activation of nuclear factor κB (NFκB) helps a variety of tumors to resist apoptosis and desensitizes them to chemotherapy, but the causes are still largely unknown. We have analysed this phenomenon in eight mutant cell lines derived from human 293 cells, selected for NFκB-dependent expression of a marker gene, and also in seven tumor-derived cell lines. Conditioned media from all of these cells stimulated the activation of NFκB (up to 30-fold) in indicator cells carrying an NFκB-responsive reporter. Therefore, secretion of extracellular factors as the cause of constitutive activation seems to be general. The mRNAs encoding several different cytokines and growth factors were greatly overexpressed in the tumor and mutant cells. The pattern of overexpression was distinct in each cell line, indicating that the phenomenon is complex. Two secreted factors whose roles in the constitutive activation of NFκB are not well defined were investigated further as pure proteins: transforming growth factor β2 (TGFβ2) and fibroblast growth factor 5 (FGF5) were both highly expressed in some mutant clones and tumor cell lines, each activated NFκB alone, and the combination was synergistic. Our data indicate that a group of different factors, expressed at abnormally high levels, can contribute singly and synergistically to the constitutive activation of NFκB in all of the mutant and tumor cell lines we studied. Since several NFκB target genes encode secreted proteins that induce NFκB, autocrine loops are likely to be ubiquitously important in the constitutive activation of NFκB in cancer. We provide the first evidence of the general, complex, and synergistic activation of NFκB in tumor and mutant cell lines through the action of secreted factors and suggest that the same explanation is likely for the constitutive activation of NFκB in cancers.

Original languageEnglish (US)
Pages (from-to)2138-2145
Number of pages8
JournalOncogene
Volume23
Issue number12
DOIs
StatePublished - Mar 18 2004
Externally publishedYes

Fingerprint

Tumor Cell Line
Intercellular Signaling Peptides and Proteins
Cytokines
Fibroblast Growth Factor 5
Neoplasms
Cell Line
Transforming Growth Factors
Conditioned Culture Medium
Nuclear Proteins
Genes
Clone Cells
Apoptosis
Drug Therapy
Messenger RNA
Proteins

Keywords

  • ELISA
  • FGF5
  • Microarrays
  • Mutant 293 cells
  • TGFβ2

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancer. / Lu, Tao; Sathe, Swati S.; Swiatkowski, Shannon M.; Hampole, Chetan V.; Stark, George R.

In: Oncogene, Vol. 23, No. 12, 18.03.2004, p. 2138-2145.

Research output: Contribution to journalArticle

Lu, Tao ; Sathe, Swati S. ; Swiatkowski, Shannon M. ; Hampole, Chetan V. ; Stark, George R. / Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancer. In: Oncogene. 2004 ; Vol. 23, No. 12. pp. 2138-2145.
@article{08c9a85cd3104b31a064d17738d50715,
title = "Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancer",
abstract = "The constitutive activation of nuclear factor κB (NFκB) helps a variety of tumors to resist apoptosis and desensitizes them to chemotherapy, but the causes are still largely unknown. We have analysed this phenomenon in eight mutant cell lines derived from human 293 cells, selected for NFκB-dependent expression of a marker gene, and also in seven tumor-derived cell lines. Conditioned media from all of these cells stimulated the activation of NFκB (up to 30-fold) in indicator cells carrying an NFκB-responsive reporter. Therefore, secretion of extracellular factors as the cause of constitutive activation seems to be general. The mRNAs encoding several different cytokines and growth factors were greatly overexpressed in the tumor and mutant cells. The pattern of overexpression was distinct in each cell line, indicating that the phenomenon is complex. Two secreted factors whose roles in the constitutive activation of NFκB are not well defined were investigated further as pure proteins: transforming growth factor β2 (TGFβ2) and fibroblast growth factor 5 (FGF5) were both highly expressed in some mutant clones and tumor cell lines, each activated NFκB alone, and the combination was synergistic. Our data indicate that a group of different factors, expressed at abnormally high levels, can contribute singly and synergistically to the constitutive activation of NFκB in all of the mutant and tumor cell lines we studied. Since several NFκB target genes encode secreted proteins that induce NFκB, autocrine loops are likely to be ubiquitously important in the constitutive activation of NFκB in cancer. We provide the first evidence of the general, complex, and synergistic activation of NFκB in tumor and mutant cell lines through the action of secreted factors and suggest that the same explanation is likely for the constitutive activation of NFκB in cancers.",
keywords = "ELISA, FGF5, Microarrays, Mutant 293 cells, TGFβ2",
author = "Tao Lu and Sathe, {Swati S.} and Swiatkowski, {Shannon M.} and Hampole, {Chetan V.} and Stark, {George R.}",
year = "2004",
month = "3",
day = "18",
doi = "10.1038/sj.onc.1207332",
language = "English (US)",
volume = "23",
pages = "2138--2145",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancer

AU - Lu, Tao

AU - Sathe, Swati S.

AU - Swiatkowski, Shannon M.

AU - Hampole, Chetan V.

AU - Stark, George R.

PY - 2004/3/18

Y1 - 2004/3/18

N2 - The constitutive activation of nuclear factor κB (NFκB) helps a variety of tumors to resist apoptosis and desensitizes them to chemotherapy, but the causes are still largely unknown. We have analysed this phenomenon in eight mutant cell lines derived from human 293 cells, selected for NFκB-dependent expression of a marker gene, and also in seven tumor-derived cell lines. Conditioned media from all of these cells stimulated the activation of NFκB (up to 30-fold) in indicator cells carrying an NFκB-responsive reporter. Therefore, secretion of extracellular factors as the cause of constitutive activation seems to be general. The mRNAs encoding several different cytokines and growth factors were greatly overexpressed in the tumor and mutant cells. The pattern of overexpression was distinct in each cell line, indicating that the phenomenon is complex. Two secreted factors whose roles in the constitutive activation of NFκB are not well defined were investigated further as pure proteins: transforming growth factor β2 (TGFβ2) and fibroblast growth factor 5 (FGF5) were both highly expressed in some mutant clones and tumor cell lines, each activated NFκB alone, and the combination was synergistic. Our data indicate that a group of different factors, expressed at abnormally high levels, can contribute singly and synergistically to the constitutive activation of NFκB in all of the mutant and tumor cell lines we studied. Since several NFκB target genes encode secreted proteins that induce NFκB, autocrine loops are likely to be ubiquitously important in the constitutive activation of NFκB in cancer. We provide the first evidence of the general, complex, and synergistic activation of NFκB in tumor and mutant cell lines through the action of secreted factors and suggest that the same explanation is likely for the constitutive activation of NFκB in cancers.

AB - The constitutive activation of nuclear factor κB (NFκB) helps a variety of tumors to resist apoptosis and desensitizes them to chemotherapy, but the causes are still largely unknown. We have analysed this phenomenon in eight mutant cell lines derived from human 293 cells, selected for NFκB-dependent expression of a marker gene, and also in seven tumor-derived cell lines. Conditioned media from all of these cells stimulated the activation of NFκB (up to 30-fold) in indicator cells carrying an NFκB-responsive reporter. Therefore, secretion of extracellular factors as the cause of constitutive activation seems to be general. The mRNAs encoding several different cytokines and growth factors were greatly overexpressed in the tumor and mutant cells. The pattern of overexpression was distinct in each cell line, indicating that the phenomenon is complex. Two secreted factors whose roles in the constitutive activation of NFκB are not well defined were investigated further as pure proteins: transforming growth factor β2 (TGFβ2) and fibroblast growth factor 5 (FGF5) were both highly expressed in some mutant clones and tumor cell lines, each activated NFκB alone, and the combination was synergistic. Our data indicate that a group of different factors, expressed at abnormally high levels, can contribute singly and synergistically to the constitutive activation of NFκB in all of the mutant and tumor cell lines we studied. Since several NFκB target genes encode secreted proteins that induce NFκB, autocrine loops are likely to be ubiquitously important in the constitutive activation of NFκB in cancer. We provide the first evidence of the general, complex, and synergistic activation of NFκB in tumor and mutant cell lines through the action of secreted factors and suggest that the same explanation is likely for the constitutive activation of NFκB in cancers.

KW - ELISA

KW - FGF5

KW - Microarrays

KW - Mutant 293 cells

KW - TGFβ2

UR - http://www.scopus.com/inward/record.url?scp=1842538759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842538759&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1207332

DO - 10.1038/sj.onc.1207332

M3 - Article

C2 - 14676835

AN - SCOPUS:1842538759

VL - 23

SP - 2138

EP - 2145

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 12

ER -